Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Primary localized cutaneous nodular amyloidosis (PLCNA) is the most rare form of primary cutaneous amyloidosis, a skin disease characterized by the accumulation of amyloid deposits in the dermis, characterized clinically by yellowish waxy crusted nodules and papules on the face, lower extremities, trunk, scalp, and genitalia and histologically by the localized deposition of immunoglobulin-derived amyloid in the papillary dermis and subcutis. PLCNA can be associated with connective tissue disorders such as SjC6grenBs syndrome and CREST syndrome.
No clinical trials have been registered for nodular cutaneous amyloidosis.
14 publications have been identified in PubMed for nodular cutaneous amyloidosis. Research spans Case Report / Case Series (64%), Review / Meta-Analysis (21%), and Other (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 64% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
3 |
21% |
Other research | 2 | 14% |
Hoegl J (2026). [PMID: 41614014](https://pubmed.ncbi.nlm.nih.gov/41614014/). *Clin Case Rep*. [Case Report / Case Series]
Janodia R (2026). [PMID: 41528921](https://pubmed.ncbi.nlm.nih.gov/41528921/). *Dermatology*. [Review / Meta-Analysis]
Danish M (2026). [PMID: 40357934](https://pubmed.ncbi.nlm.nih.gov/40357934/). *Indian J Dermatol Venereol Leprol*. [Other]
Zhuang M (2025). [PMID: 41145181](https://pubmed.ncbi.nlm.nih.gov/41145181/). *CMAJ*. [Case Report / Case Series]
Takahashi H (2025). [PMID: 39126225](https://pubmed.ncbi.nlm.nih.gov/39126225/). *J Dermatol*. [Other]
Wang QX (2025). [PMID: 39957318](https://pubmed.ncbi.nlm.nih.gov/39957318/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
Hirao D (2025). [PMID: 41583297](https://pubmed.ncbi.nlm.nih.gov/41583297/). *Cureus*. [Case Report / Case Series]
Almukhlifi A (2025). [PMID: 40376382](https://pubmed.ncbi.nlm.nih.gov/40376382/). *Cureus*. [Case Report / Case Series]
Yu W (2025). [PMID: 40738804](https://pubmed.ncbi.nlm.nih.gov/40738804/). *Eur J Intern Med*. [Case Report / Case Series]
Shah S (2025). [PMID: 41280259](https://pubmed.ncbi.nlm.nih.gov/41280259/). *Clin Case Rep*. [Case Report / Case Series]